Experimental Hematology

Papers
(The TQCC of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Simplified murine multipotent progenitor isolation scheme: Establishing a consensus approach for multipotent progenitor identification48
Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials46
Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis44
Yin and Yang: The dual effects of interferons on hematopoiesis43
Periodontitis and circulating blood cell profiles: a systematic review and meta-analysis41
Erythroid enucleation: a gateway into a “bloody” world39
The erythroblastic island niche: modeling in health, stress, and disease32
Mechanisms of lenalidomide sensitivity and resistance30
Hypoxia promotes erythroid differentiation through the development of progenitors and proerythroblasts29
The RUNX1/RUNX1T1 network: translating insights into therapeutic options23
Single-cell insights into the hematopoietic generation of T-lymphocyte precursors in mouse and human23
Hematopoietic stem and progenitor cells outside the bone marrow: where, when, and why23
Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia20
The Akt–mTOR network at the interface of hematopoietic stem cell homeostasis20
Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells18
Hematopoietic stem cell gene editing and expansion: State-of-the-art technologies and recent applications16
Human CD34-negative hematopoietic stem cells: The current understanding of their biological nature14
Understanding of the crosstalk between normal residual hematopoietic stem cells and the leukemic niche in acute myeloid leukemia13
Buffering noise: KAT2A modular contributions to stabilization of transcription and cell identity in cancer and development13
Molecular Basis of Hematological Disease Caused by Inherited or Acquired RUNX1 Mutations12
HOXA9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia12
Recent advances in T-cell lymphoid neoplasms12
Mitochondria in human acute myeloid leukemia cell lines have ultrastructural alterations linked to deregulation of their respiratory profiles12
CRISPR–Cas9 gene editing induced complex on-target outcomes in human cells12
VEGF, FGF2, and BMP4 regulate transitions of mesoderm to endothelium and blood cells in a human model of yolk sac hematopoiesis12
Interaction of the inflammatory response and megakaryocytes in COVID-19 infection12
Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learned11
Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches11
Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms11
Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia11
Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation11
Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A11
Single-cell technologies and analyses in hematopoiesis and hematological malignancies11
Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease10
TBL1X: At the crossroads of transcriptional and posttranscriptional regulation10
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment10
Arid2 regulates hematopoietic stem cell differentiation in normal hematopoiesis10
Perspective: sensitive detection of residual lymphoproliferative disease by NGS and clonal rearrangements—how low can you go?10
Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia10
Stayin’ alive: BCL-2 proteins in the hematopoietic system10
Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesis10
Reading the B-cell receptor immunome in chronic lymphocytic leukemia: revelations and applications10
Macrophages form erythropoietic niches and regulate iron homeostasis to adapt erythropoiesis in response to infections and inflammation10
Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: a novel role through transferrin receptors9
The regulation roles of Ca2+ in erythropoiesis: What have we learned?9
Salvianolic acid A inhibits the growth of diffuse large B-cell lymphoma through MAPK pathways9
How Hematopoietic Stem Cells Respond to Irradiation: Similarities and Differences between Low and High Doses of Ionizing Radiations9
Chronic inflammation can transform the fate of normal and mutant hematopoietic stem cells9
Eflapegrastim's enhancement of efficacy compared with pegfilgrastim in neutropenic rats supports potential for same-day dosing9
Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance9
TLR7/8 agonist treatment induces an increase in bone marrow resident dendritic cells and hematopoietic progenitor expansion and mobilization9
Beyond “to divide or not to divide”: Kinetics matters in hematopoietic stem cells9
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV9
Metformin-induced suppression of Nemo-like kinase improves erythropoiesis in preclinical models of Diamond–Blackfan anemia through induction of miR-26a9
Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy9
Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors8
Quantitative Analysis of Sympathetic and Nociceptive Innervation Across Bone Marrow Regions in Mice8
Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes8
Distinct effects of chondroitin sulfate on hematopoietic cells and the stromal microenvironment in bone marrow hematopoiesis8
Pseudogenes and their potential functions in hematopoiesis8
Intrinsically magnetic susceptibility in human blood and its potential impact on cell separation: Non-classical and intermediate monocytes have the strongest magnetic behavior in fresh human blood8
Visible and near-infrared hyperspectral imaging techniques allow the reliable quantification of prognostic markers in lymphomas: A pilot study using the Ki67 proliferation index as an example8
Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia8
Two faces of RUNX3 in myeloid transformation8
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage8
Adult murine hematopoietic stem cells and progenitors: an update on their identities, functions, and assays8
Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA8
Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions8
Recurrent transcriptional responses in AML and MDS patients treated with decitabine8
Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis8
CFU-S assay: a historical single-cell assay that offers modern insight into clonal hematopoiesis7
Mechanisms of resistance to targeted therapies for relapsed or refractory acute myeloid leukemia7
Hematopoietic stem cell (HSC) divisional memory: The journey of mitochondrial metabolism through HSC division7
C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module7
Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes7
Control of fetal globin expression in man: new opportunities to challenge past discoveries7
hnRNPK/Beclin1 signaling regulates autophagy to promote imatinib resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia cells7
miR-495-3p sensitizes BCR-ABL1-expressing leukemic cells to tyrosine kinase inhibitors by targeting multidrug resistance 1 gene in T315I mutated cells6
HSC-derived fatty acid oxidation in steady-state and stressed hematopoiesis6
Transcriptional reprogramming in neonatal hematopoietic stem and progenitor cells6
Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation6
ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells6
Lipid uptake in chronic lymphocytic leukemia6
Integrins and their role in megakaryocyte development and function6
Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment6
KDM6A, a histone demethylase, regulates stress hematopoiesis and early B-cell differentiation6
Role of ASXL1 in hematopoiesis and myeloid diseases6
Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells6
Signal-transducing adaptor protein-1 and protein-2 in hematopoiesis and diseases6
A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency6
Single-cell analysis of erythropoiesis in Rpl11 haploinsufficient mice reveals insight into the pathogenesis of Diamond–Blackfan anemia6
The multifaceted role of mitochondria in HSC fate decisions: energy and beyond5
Differential expression of hydroxyurea transporters in normal and polycythemia vera hematopoietic stem and progenitor cell subpopulations5
miRNA-223-3p modulates ibrutinib resistance through regulation of the CHUK/Nf-κb signaling pathway in mantle cell lymphoma5
The (intra-aortic) hematopoietic cluster cocktail: what is in the mix?5
Serum metabolomic profiling correlated with ISS and clinical outcome for multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation5
Epigenetic maintenance strategies after allogeneic stem cell transplantation in acute myeloid leukemia5
Function of the P2X7 receptor in hematopoiesis and leukemogenesis5
Chronic lymphocytic leukemia–like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia5
Overlooking the obvious? On the potential of treatment alterations to predict patient-specific therapy response5
Human, mouse, and dog bone marrow show similar mesenchymal stromal cells within a distinctive microenvironment5
Reduced IFN-γ levels along with changes in hematologic and immunologic parameters are key to COVID-19 severity in Bangladeshi patients5
RUNX1 Inhibition Using Lipid Nanoparticle-Mediated Silencing RNA Delivery as an Effective Treatment for Acute Leukemias5
Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells5
Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia5
Single-cell analysis of cultured bone marrow stromal cells reveals high similarity to fibroblasts in situ5
Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax4
AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse4
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib4
Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation4
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells4
New insight into the causes, consequences, and correction of hematopoietic stem cell aging4
α4-Integrin deficiency in human CD34+ cells engenders precocious erythroid differentiation but inhibits enucleation4
Immune composition and its association with hematologic recovery after chemotherapeutic injury in acute myeloid leukemia4
Extracellular vesicles tell all: How vesicle-mediated cellular communication shapes hematopoietic stem cell biology with increasing age4
Chronic inflammation promotes cancer progression as a second hit4
Dynamic DNA methylation reveals novel cis-regulatory elements in mouse hematopoiesis4
CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia4
Erythropoietin regulates metabolic response in mice via receptor expression in adipose tissue, brain, and bone4
How nutrition regulates hematopoietic stem cell features4
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study4
Metabolic regulation of erythrocyte development and disorders4
Radiation-free reduced-intensity hematopoietic stem cell transplantation with in vivo T-cell depletion from matched related and unrelated donors for Fanconi anemia: prognostic factor analysis4
O-GlcNAcylation: Implications in normal and malignant hematopoiesis4
CD99 in malignant hematopoiesis4
Translational research for bone marrow failure patients4
Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions4
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes4
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations3
CRLF2 overexpression results in reduced B-cell differentiation and upregulated E2F signaling in the Dp16 mouse model of Down syndrome3
Megakaryocyte–stromal cell interactions: Effect on megakaryocyte proliferation, proplatelet production, and survival3
Posttransplant cyclophosphamide contributes to the impairment of the graft-versus-leukemia effect and the amelioration of graft-versus-host disease with the suppression of alloreactive T cells in a mu3
Pacritinib protects dendritic cells more efficiently than ruxolitinib3
EVI1 protein interaction dynamics: Targetable for therapeutic intervention?3
Physical interaction between BAALC and DBN1 induces chemoresistance in leukemia3
Targeting elevated heme levels to treat a mouse model for Diamond-Blackfan Anemia3
3113 – FORTY-EIGHT WEEK EFFICACY AND SAFETY OF PEGCETACOPLAN IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND SUBOPTIMAL RESPONSE TO PRIOR ECULIZUMAB TREATMENT3
Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasms3
Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm3
Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1 mouse model3
The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemia3
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro3
Bone marrow transplantation without myeloablative conditioning in a mouse model for Diamond-Blackfan anemia corrects the disease phenotype3
Transplantation of T-cell receptor α/β-depleted allogeneic bone marrow in nonhuman primates3
EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy3
Bortezomib enhances G-CSF-induced hematopoietic stem cell mobilization by decreasing CXCL12 levels and increasing vascular permeability3
Rapamycin inhibits the progression of human acute myeloid leukemia by regulating the circ_0094100/miR-217/ATP1B1 axis3
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells3
Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations3
MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target3
Differential effects of Huaier aqueous extract on human CD4+T lymphocytes from patients with primary immune thrombocytopenia3
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing3
Relationship of T- and B-cell kinetics to clinical response in patients with relapsed/refractory non-Hodgkin lymphoma treated with blinatumomab3
Engineered hematopoietic and immune cells derived from human pluripotent stem cells3
Mitochondrial Deep Dive into Hematopoietic Stem Cell Dormancy: Not Much Glycolysis but Plenty of Sluggish Lysosomes3
Fetal allotransplant recipients are resistant to graft-versus-host disease2
Forged in the fire: Lasting impacts of inflammation on hematopoietic progenitors2
IOX1 Fails to Reduce α-Globin and Mediates γ-Globin Silencing in Adult β0-Thalassemia/Hemoglobin E Erythroid Progenitor Cells2
Immune control in acute myeloid leukemia2
Fetal sheep support the development of hematopoietic cells in vivo from human induced pluripotent stem cells2
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL2
Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1low model of myelofibrosis2
Lineage- and Stage-Specific Oncogenicity of IRF42
Heme-dependent induction of mitophagy program during differentiation of murine erythroid cells2
To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice2
5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-92
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination re2
Metabolic regulation of aged hematopoietic stem cells: key players and mechanisms2
Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis2
Cell fate decision in erythropoiesis: Insights from multiomics studies2
Nucleic acid-induced inflammation on hematopoietic stem cells2
Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis2
From cell to cell: Identification of actionable targets in bone marrow fibrosis using single-cell technologies2
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms2
Unifying targeted therapy for leukemia in the era of PARP inhibition2
A Bloody Feast—Nutritional Regulation of Hematopoiesis2
Distinct roles of the preparatory and payoff phases of glycolysis in hematopoietic stem cells2
Epidemiology of Chronic Lymphocytic Leukemia in Sardinia, Italy (1974–2003)2
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent2
Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome2
Ruxolitinib ameliorates progressive anemia and improves survival during episodes of emergency granulopoiesis in Fanconi C–/– mice2
Complexities of modeling the bone marrow microenvironment to facilitate hematopoietic research2
MiR-455-3p mediates PPARα through UBN2 to promote apoptosis and autophagy in acute myeloid leukemia cells2
RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia2
The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia2
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia2
CCL8 deficiency in the host abrogates early mortality of acute graft-versus-host disease in mice with dysregulated IL-6 expression2
m6A RNA modifications: Key regulators of normal and malignant hematopoiesis2
An In Vivo Model for Elucidating the Role of an Erythroid-Specific Isoform of Nuclear Export Protein Exportin 7 (Xpo7) in Murine Erythropoiesis2
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone2
Persistent expression of microRNA-125a targets is required to induce murine hematopoietic stem cell repopulating activity2
Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation2
Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of Crbn2
Human umbilical cord mesenchymal stem cells ameliorate acute graft-versus-host disease by elevating phytosphingosine1
Zeb1 maintains long-term adult hematopoietic stem cell function and extramedullary hematopoiesis1
Targeting positive cofactor 4 induces autophagic cell death in MYC-expressing diffuse large B-cell lymphoma1
Functional and molecular profiling of hematopoietic stem cells during regeneration1
Hematopoietic stem cells depend on HIM and HER1
Assay optimization for the objective quantification of human multilineage colony-forming units1
Minor introns impact on hematopoietic malignancies1
Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD121
Bmi1 induction protects hematopoietic stem cells against pronounced long-term hematopoietic stress1
Optimization of pre-enrichment strategies for mouse hematopoietic stem cell isolation and metabolomic analysis1
Building bones for blood and beyond: the growing field of bone marrow niche model development1
Remembering Professor Connie Eaves: an exceptional researcher, mentor and friend1
2015 – A MOUSE MODEL WITH HIGH CLONAL BARCODE DIVERSITY FOR JOINT LINEAGE, TRANSCRIPTOMIC, AND EPIGENOMIC PROFILING IN SINGLE CELLS1
Cdkn2a inactivation promotes malignant transformation of mouse immature thymocytes before the β-selection checkpoint1
Hydroxyurea Decouples Persistent F-Cell Elevation and Induction of γ-Globin1
The hematopoietic stem cell expansion niche in fetal liver: Current state of the art and the way forward1
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1–RUNX1T11
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation1
3077 – DO MURINE MSCS EVADE IMMUNE REACTIONS IN VIVO?1
Harnessing Single-Cell Technologies in the Search for New Therapies for Diamond–Blackfan Anemia Syndrome1
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils1
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs1
Antileukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome1
3095 – IMMUNE THROMBOCYTOPENIA AND BONE MARROW HEMOPHAGOCYTOSIS ASSOCIATED WITH SARS COV-21
Murine double minute X plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies1
2028 – CYCLOPHILIN A REGULATES PROTEIN PHASE SEPARATION AND MITIGATES HEMATOPOIETIC STEM CELL AGING1
3014 – NON-CANONICAL EZH2 DRIVES RETINOIC ACID RESISTANCE OF VARIANT ACUTE PROMYELOCYTIC LEUKEMIAS1
Serum B-Cell maturation antigen is an independent prognostic marker in previously untreated chronic lymphocytic leukemia1
3030 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AND 7A AS POTENTIAL NICHE FACTORS1
Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer1
3161 – CELLULAR AND MOLECULAR EFFECTS OF DMPGE₂ RADIOMITIGATION IN MOUSE AND HUMAN BONE MARROW CELLS IN VIVO USING C57BL/6 AND HUMANIZED NSG MOUSE MODELS OF ACUTE RADIATION SYNDROME1
Chromatin organization in myelodysplastic syndrome1
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments1
3218 – CIRCULATING MICRORNAS IN CEREBROSPINAL FLUID AND PLASMA: SENSITIVE TOOL FOR DETECTION OF SECONDARY CNS INVOLVEMENT, MONITORING OF THERAPY AND PREDICTION OF CNS RELAPSE IN AGGRESSIVE B-NHL LYMPH1
3022 – CELL SIZE IS A DETERMINANT OF STEM CELL POTENTIAL DURING AGING1
Mechanistic and kinetic insights into transcription factor biology via acute protein depletion1
Critical role of MXRA7 in differentiation blockade in human acute promyelocytic leukemia cells1
Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma1
3054 – CLINICALLY MEANINGFUL AND LONG-TERM IMPROVEMENTS IN FATIGUE WITH THE C3 INHIBITOR PEGCETACOPLAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A POST HOC ANALYSIS FROM THE PEGASUS TRIAL AT WEEK 481
3227 – STAG2-COHESIN LOSS ATTENUATES FLT3ITD MYELOID BLAST EXPANSION YET PRESERVES MUTANT HSCS1
Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors1
3020 – RNA-INTERFERENCE SCREEN IDENTIFIES MTA1 AS A REGULATOR OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS1
Identification of red blood cell distribution width as a prognostic factor in acute myeloid leukemia1
Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs1
Corrigendum to <Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia’>1
Transfusions with laboratory-grown red blood cells: a new development in science1
3018 – BIOENGINEERED HUMAN MICROTISSUE MODEL OF HEALTHY AND LEUKEMIC BONE MARROW1
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma1
Proteoglycans regulate protein tyrosine phosphatase receptor σ organization on hematopoietic stem/progenitor cells1
From Metcalf to myeloproliferative neoplasms – a personal journey1
Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes1
Biomaterial-assisted therapeutic cell production and modification in vivo1
Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen1
3195 – LONG-TERM EX VIVO HEMATOPOIETIC STEM CELL (HSC) EXPANSION USING NOVEL BONE-LINING REINVIGORATING MESENCHYMAL STROMAL CELLS (RMSCS)1
3137 – ACUTE MYLOID LEUKEMIA KEY MUTATIONS IN THE LENS OF RAMAN MICROSCOPY.1
Metabolic regulation in erythroid differentiation by systemic ketogenesis in fasted mice1
Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing1
0.15727400779724